The effect of topical steroid nasal spray, Mometasone Furoate Hydrate, on the slpeep sleep quality of pateints with perennial allergic rhinitis

The effect of topical steroid nasal spray, Mometasone Furoate Hydrate, on the slpeep sleep quality of pateints with perennial allergic rhinitis - The effect of topical steroid nasal spray on the slpeep sleep quality of pateints with perennial allergic rhinitis

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000003233

Enrollment

Registered

2010-02-22

Start date

2009-10-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

perennial allergic rhinitis

Interventions

It is given the intranasal spray containing topical steroid (Mometasone Furoate Hydrate), once per day (two pushes once) for 14days. It is given the intranasal spray containing placebo materials once

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: CAP-RAST against the antigens causing for perennial allergy over class 2, with symptons of allergic rhinitis

Exclusion criteria

Exclusion criteria: Prgnancy, potential pregnancy, and breast-feeding patient.

Design outcomes

Primary

Measure	Time frame
Efficacy of topical nasal steroid	—

Secondary

Measure	Time frame
Concentration of nitric oxide in the upper or lower airways	—

Countries

Japan

Contacts

Public ContactTakechiyo Yamada

Faculty of medicine, University of Fukui Department of Otorhinolaryngology

ymdtkcy@u-fukui.ac.jp0776-61-8407

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026